INTERNATIONAL PATENT: SHANGHAI RNACURE BIOPHARMA CO., LTD., 上海蓝鹊生物医药有限公司, FUDAN UNIVERSITY, 复旦大学 FILES APPLICATION FOR "ANTI-SARS-COV-2 VIRUS PROTEIN OR MRNA VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF"

Posted On: 2025-04-05

GENEVA, April 5 -- SHANGHAI RNACURE BIOPHARMA CO., LTD. (Room 103-287, No. 2, 99 South Changjiang RoadBaoshan District, Shanghai 201906), 上海蓝鹊生物医药有限公司 (中国上海市宝山区长江南路99弄2号103室-287), FUDAN UNIVERSITY (220 Handan RoadYangpu District, Shanghai 200433), 复旦大学 (中国上海市杨浦区邯郸路220号) filed a patent application (PCT/CN2024/119716) for "ANTI-SARS-COV-2 VIRUS PROTEIN OR MRNA VACCINE, PREPARATION METHOD THEREFOR, AND USE THEREOF" on Sep 19, 2024. With publication...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: SHANGHAI RNACURE BIOPHARMA CO., LTD., 上海蓝鹊生物医药有限公司, FUDAN UNIVERSITY, 复旦大学 FILES APPLICATION FOR "ANTI-SARS-COV-2 VIRUS PROTEIN OR MRNA VACCINE, PREPARATION METHOD THEREFOR AND USE THEREOF"